SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Alembic Pharmaceuticals informs about details of loss of certificate

20 Dec 2023 Evaluate
Alembic Pharmaceuticals has enclosed the intimation dated 20th December, 2023 received from Link Intime India, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s). Details enclosed.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

765.50 1.95 (0.26%)
22-Apr-2026 12:21 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.40
Dr. Reddys Lab 1220.85
Cipla 1233.90
Zydus Lifesciences 930.90
Lupin 2306.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×